Culbertson A N & Co’s Zimmer Biomet ZBH Stock Holding History

Culbertson A N & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,248	Closed	-$472K	–	144
2025 Q4	$472K	Sell	5,248 -715	-12%	-$67.8K	0.06%	110
2025 Q3	$587K	Sell	5,963 -35	-0.6%	-$3.47K	0.08%	107
2025 Q2	$547K	Hold	5,998	–	–	0.08%	105
2025 Q1	$679K	Hold	5,998	–	–	0.11%	100
2024 Q4	$634K	Buy	5,998 +185	+3%	+$19.9K	0.1%	104
2024 Q3	$628K	Buy	5,813 +550	+10%	+$60K	0.1%	104
2024 Q2	$571K	Hold	5,263	–	–	0.1%	103
2024 Q1	$695K	Sell	5,263 -440	-8%	-$55K	0.12%	95
2023 Q4	$694K	Sell	5,703 -45	-0.8%	-$5.02K	0.13%	97
2023 Q3	$645K	Sell	5,748 -260	-4%	-$33K	0.13%	95
2023 Q2	$875K	Sell	6,008 -40	-0.7%	-$5.44K	0.17%	87
2023 Q1	$781K	Sell	6,048 -1,091	-15%	-$137K	0.16%	89
2022 Q4	$910K	Sell	7,139 -295	-4%	-$34.2K	0.19%	88
2022 Q3	$777K	Sell	7,434 -946	-11%	-$104K	0.18%	86
2022 Q2	$880K	Sell	8,380 -390	-4%	-$46.3K	0.19%	87
2022 Q1	$1.12M	Sell	8,770 -526	-6%	-$63.4K	0.21%	86
2021 Q4	$1.15M	Buy	9,296 +1,370	+17%	+$179K	0.22%	84
2021 Q3	$1.13M	Buy	7,926 +1,030	+15%	+$152K	0.23%	83
2021 Q2	$1.08M	Sell	6,896 -93	-1%	-$15.1K	0.22%	86
2021 Q1	$1.09M	Sell	6,989 -104	-1%	-$16.1K	0.24%	83
2020 Q4	$1.06M	Sell	7,093 -5	-0.1%	-$706	0.25%	79
2020 Q3	$938K	Sell	7,098 -811	-10%	-$106K	0.25%	79
2020 Q2	$917K	Sell	7,909 -31	-0.4%	-$3.57K	0.25%	78
2020 Q1	$779K	Buy	7,940 +67	+0.9%	+$8.78K	0.25%	77
2019 Q4	$1.14M	Sell	7,873 -52	-0.7%	-$7.18K	0.29%	75
2019 Q3	$1.06M	Buy	7,925 +500	+7%	+$64.6K	0.29%	77
2019 Q2	$849K	Buy	7,425 +103	+1%	+$12.1K	0.24%	80
2019 Q1	$908K	Sell	7,322 -428	-6%	-$48.6K	0.26%	80
2018 Q4	$780K	Buy	7,750 +46	+0.6%	+$5.17K	0.25%	79
2018 Q3	$983K	Buy	7,704 +309	+4%	+$36.7K	0.27%	75
2018 Q2	$800K	Hold	7,395	–	–	0.24%	76
2018 Q1	$783K	Sell	7,395 -2,030	-22%	-$236K	0.23%	76
2017 Q4	$1.1M	Sell	9,425 -154	-2%	-$17.4K	0.31%	72
2017 Q3	$1.09M	Buy	9,579 +34	+0.4%	+$3.92K	0.33%	71
2017 Q2	$1.19M	Sell	9,545 -294	-3%	-$34.9K	0.38%	68
2017 Q1	$1.17M	Sell	9,839 -139	-1%	-$15.8K	0.38%	67
2016 Q4	$1M	Buy	9,978 +1,453	+17%	+$156K	0.34%	69
2016 Q3	$1.08M	Buy	8,525 +643	+8%	+$79.4K	0.38%	63
2016 Q2	$921K	Buy	7,882 +62	+0.8%	+$7.02K	0.34%	67
2016 Q1	$810K	Hold	7,820	–	–	0.31%	65
2015 Q4	$779K	Sell	7,820 -388	-5%	-$38K	0.31%	68
2015 Q3	$749K	Sell	8,208 -309	-4%	-$31K	0.32%	69
2015 Q2	$903K	Sell	8,517 -508	-6%	-$56.2K	0.35%	66
2015 Q1	$1.03M	Hold	9,025	–	–	0.41%	62
2014 Q4	$994K	Sell	9,025 -122	-1%	-$12.9K	0.41%	62
2014 Q3	$893K	Hold	9,147	–	–	0.38%	63
2014 Q2	$922K	Sell	9,147 -87	-0.9%	-$8.49K	0.4%	62
2014 Q1	$848K	Hold	9,234	–	–	0.4%	63
2013 Q4	$835K	Sell	9,234 -976	-10%	-$84.5K	0.41%	62
2013 Q3	$814K	Hold	10,210	–	–	0.44%	62
2013 Q2	$743K	Buy	+10,210	New	+$763K	0.42%	62

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Culbertson A N & Co's ZBH Position: Q1 2026 in Review

Culbertson A N & Co sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 5,248 shares — an estimated $472K sold.

Culbertson A N & Co first reported a position in ZBH in Q2 2013 and held it in 51 quarters. The position peaked at $1.19M in Q2 2017. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Culbertson A N & Co reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Culbertson A N & Co sold 5,248 Zimmer Biomet shares in Q1 2026, an estimated $472K.
Culbertson A N & Co first reported a position in Zimmer Biomet in Q2 2013 and held it in 51 quarters.
Culbertson A N & Co's Zimmer Biomet position peaked at $1.19M in Q2 2017.
916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Culbertson A N & Co's 13F filing for Q1 2026, filed 12 May 2026.